Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Clinical Nephrology|March 1, 2015
Current ESRD burden and its future trend in Beijing, ChinaLiangying Gan, Li ZuoInternational Urology and Nephrology|September 17, 2014
Comparison of patient survival between hemodialysis and peritoneal dialysis in a single Chinese centerBei Wu, Mei Wang, Liangying Gan, et al.Endocrine|October 2, 2022
Roxadustat improves renal osteodystrophy by dual regulation of bone remodelingLuyao Li, Afang Li, Liangying Gan, et al.International Journal of Clinical and Experimental Pathology|July 21, 2015
Ultrastructural pathological features of unilateral renal artery stenosis in the ratsXin Liu, Yonghui Mao, Xuemei He, et al.Blood Purification|May 26, 2021
COVID-19 Prevention and Control in Dialysis Centers during the Pandemic: A Single-Center ExperienceLiangying Gan, Bing Yang, Yan Wang, et al.Journal of Orthopaedic Surgery and Research|May 21, 2022
Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathwayLuyao Li, Afang Li, Li Zhu, et al.Journal of Clinical Medicine|February 25, 2023
The Effect of Metabolic Syndrome and Its Individual Components on Renal Function: A Meta-AnalysisXu Li, Qichen Liang, Junfeng Zhong, et al.Renal Failure|March 28, 2022
Efficacy and safety of expanded hemodialysis in hemodialysis patients: a meta-analysis and systematic reviewYuchao Zhao, Liangying Gan, Qingyu Niu, et al.Nephrology (Carlton, Vic.)|July 25, 2019
Different type and dosage of heparin were not associated with the progression of coronary artery calcification in haemodialysis patientsQingyu Niu, Shuo Yang, Liangying Gan, et al.BMC Nephrology|July 27, 2020
The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patientsQingyu Niu, Huiping Zhao, Li Zuo, et al.Pageof 5